• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2501685 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2025-05-09 Guangdong Zhongsheng Pharmaceutical Co Ltd view
CYHS2501346 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2025-04-09 Chengdu Push Pharmaceutical Co Ltd view
CYHS2500349 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2025-01-17 Guangzhoudaguang Pharmaceutical Co Ltd view
CYHS2404471 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2024-12-24 Nanjing Healthnice Pharmaceutical Co Ltd view
CYHS2404335 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2024-12-13 Shijiazhuang NO4 Pharmaceutical Co Ltd view
CYHS2402051 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2024-07-06 Wuhan Wujing Pharmaceutical Co Ltd;Nanjing H&D Pharmaceutical Technology Co Ltd view
CYHS2401666 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2024-06-04 Renheng Pharm Limited;Hefei Huawei Pharmaceutical Co Ltd view
CYHS2401321 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs(4) Generic Drug 2024-04-30 Zhejiang Shifangji Pharmaceutical Technology Co Ltd;Zhejiang Shapuaisi Pharmaceutical Co Ltd view
JYHZ2300448 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs License Renew 2023-12-06 SA Alcon-Couvreur NV;Future Health Pharma GmbH;Ocumension Therapeutics(Suzhou)Co Ltd view
CYHB2202058 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2022-11-11 Ocumension Therapeutics(Suzhou)Co Ltd view
JYHB2200193 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2022-04-11 SA Alcon-Couvreur NV;Future Health Pharma GmbH view
JYHB2100058 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2021-01-14 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Pharma Schweiz AG Certificate Issued 2021-02-01 view
JYHB2002020 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2020-10-15 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Filed 2020-11-05 view
JYHB2000819 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2020-06-12 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Filed 2020-06-19 view
JYHZ1900078 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs License Renew 2019-03-25 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Certificate Issued 2019-11-14 view
JYHB1801317 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2018-11-16 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Certificate Issued 2019-03-11 view
JYHB1801198 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2018-10-10 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Filed 2018-10-22 view
JYHB1800335 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2018-04-02 爱尔康(中国)眼科产品有限公司 Alcon (China) Ophthalmic Product Co Ltd;SA Alcon-Couvreur NV;Novartis Europharm Ltd Certificate Issued 2018-05-02 view
JYHB1601186 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2016-09-18 爱尔康(中国)眼科产品有限公司 Alcon (China) Ophthalmic Product Co Ltd;Alcon Singapore Manufacturing Pte Ltd Certificate Issued 2018-02-24 view
JYHB1601185 富马酸依美斯汀滴眼液 emedastine difumarate Eye drops Chemical Drugs Supplementary Application 2016-09-18 爱尔康(中国)眼科产品有限公司 Alcon (China) Ophthalmic Product Co Ltd;Alcon Singapore Manufacturing Pte Ltd Certificate Issued 2018-02-24 view